ANI Pharmaceuticals, Inc. (ANIP)
73.92
-0.75
(-1.00%)
USD |
NASDAQ |
Mar 23, 16:00
74.37
+0.45
(+0.61%)
After-Hours: 20:00
ANI Pharmaceuticals Total Assets (Quarterly) : 1.440B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CorMedix, Inc. | 877.63M |
| Catalyst Pharmaceuticals, Inc. | 1.107B |
| Castle Biosciences, Inc. | 609.21M |
| Liquidia Corp. | 331.57M |
| Allogene Therapeutics, Inc. | 415.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 899.65M |
| Shareholders Equity (Quarterly) | 540.72M |
| Debt to Equity Ratio | 1.162 |
| Current Ratio | 2.707 |
| Net Debt Paydown Yield | 0.25% |